Myosin Therapeutics Awarded Florida Cancer Innovation Fund Grant to Support STAR-GBM Clinical Trial
JUPITER, Fla., March 24, 2026 /PRNewswire/ -- Myosin Therapeutics today announced that it has been awarded $2 million in funding from the Florida Department of Health through the Casey DeSantis Florida Cancer Innovation Fund (FCIF) to support the company's STAR-GBM Phase 1/2 clinical...
CP
cision pr newswire
via Pr Newswire
Updated 1h ago

Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...

